MedPath

Online Self-compassion Intervention on Paternal Perinatal Depression

Not Applicable
Not yet recruiting
Conditions
Postpartum Depression (PPD)
Registration Number
NCT07077759
Lead Sponsor
Hong Kong Metropolitan University
Brief Summary

To investigate the feasibility, acceptability, and preliminary effectiveness of an online mindfulness and self-compassion intervention for the mental health in fathers experiencing paternal perinatal depression (PPD).

Detailed Description

The pilot RCT will be assessed using an online survey and semi-structured individual interviews. Preliminary effectiveness measures include self-compassion, emotion regulation, resilience, and PPD measured at baseline, immediate post-intervention, and 2-month follow-up. Mixed-effects models will test changes between groups, while directed content analysis will be employed for qualitative data.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Male
Target Recruitment
40
Inclusion Criteria
  1. aged 18 years or above; 2) the biological father who is expecting or the biological father of infants within 12 months old; 3) positive in depressive symptom screening with a PHQ-9 scored 9 or above; 4) sufficient comprehension of Cantonese; 5) currently live in Hong Kong; and 6) able to provide informed consent.
Exclusion Criteria
  1. currently experiencing psychosis; 2) having an intellectual disability; 3) experiencing current suicidal ideation; 4) participation in a similar study or received similar services in the past year.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Paternal perinatal depressionFrom enrollment to the end of treatment at 2 months.

(iv) Paternal perinatal depression will be measured using the Chinese version of the 9-item Patient Health Questionnaire (PHQ-9). The scale is reliable in the Chinese population (Cronbach's α = 0.82).

Secondary Outcome Measures
NameTimeMethod
Emotion regulationFrom enrollment to the end of treatment at 2 months

Emotion regulation will be measured by the 10-item Emotion Regulation Questionnaire. The Cronbach's alpha was 0.82 and 0.77 for cognitive reappraisal and suppression, respectively.

Self-compassionFrom enrollment to the end of intervention at 2 months

Self-compassion will be measured using the short version of the self-compassion scale (Raes et al., 2011). The scale has demonstrated good internal consistency in Chinese sexual minorities (Cronbach's alpha = 0.87)

ResilienceFrom enrollment to the end of treatment at 2 months.

Resilience will be measured by the six-item brief resilience scale (BRS).

Trial Locations

Locations (1)

Hong Kong Metropolitan University

🇭🇰

Hong Kong, Hong Kong

Hong Kong Metropolitan University
🇭🇰Hong Kong, Hong Kong
Haixia Ma, PhD
Contact
phxma@hkmu.edu.hk

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.